Clinical Trials Logo

Safety Issues clinical trials

View clinical trials related to Safety Issues.

Filter by:

NCT ID: NCT04169685 Recruiting - Safety Issues Clinical Trials

Dexmedetomidine for Sedation Undergoing Bronchoscopy

Start date: April 1, 2017
Phase:
Study type: Observational

Several sedatives or analgesics can be used to achieve appropriate levels of sedation for endoscopic procedures. Dexmedetomide is notable for providing sedation without respiratory depression. We hypothesized dexmedetomide is more suitable for sedation of bronchoscopy than other sedative drugs.

NCT ID: NCT03838341 Recruiting - Atrial Fibrillation Clinical Trials

Stand-alone Totally Thoracoscopic Left Atrial Appendage Occlusion Using AtriClip® Device in Non-valvular Atrial Fibrillation.

THORACS-LAAO
Start date: June 8, 2015
Phase:
Study type: Observational [Patient Registry]

Polish multicenter registry to assess safety and durability of totally thoracoscopic left atrial appendage occlusion for stroke prevention in atrial fibrillation.

NCT ID: NCT03794843 Recruiting - Safety Issues Clinical Trials

Bioavailability Comparison Study of Two Types of Nimodipine Injections in Healthy Volunteers

Start date: August 23, 2018
Phase: Early Phase 1
Study type: Interventional

A Randomized, Open-label, Single Dose, Two Formulation, Two Period, Double Cross Over Bioavailability Comparison Study of two types of Nimodipine Injections in Healthy Volunteers.

NCT ID: NCT03791372 Recruiting - Safety Issues Clinical Trials

Clinical Effect and Safety of Autologous Umbilical Cord Blood Transfusion in the Treatment of Cerebral Palsy

Start date: October 10, 2017
Phase: Phase 1
Study type: Interventional

To study the clinical efficacy and safety of autologous umbilical cord blood transfusion in the treatment of cerebral palsy.

NCT ID: NCT03620435 Recruiting - Safety Issues Clinical Trials

Trimodal Therapy Plus Atezolizumab in Muscle-invasive Bladder Cancer

Start date: May 1, 2018
Phase: Phase 2
Study type: Interventional

This is a single arm phase II trial to (1) evaluate safety and toxicity profile of intravenous Atezolizumab (anti-PDL-1) administered in combination with TMT in patients with MIBC, (2) To determine the loco-regional control rate (LCR) of TMT combined with PDL-1 blockade.

NCT ID: NCT03527615 Recruiting - Safety Issues Clinical Trials

Clinical Pharmacist Anticoagulant Stewardship

Start date: January 1, 2017
Phase:
Study type: Observational

Initiative to improve direct anticoagulant utilization involving programmatic review by clinical pharmacists in collaboration with multidisciplinary team.

NCT ID: NCT03399695 Recruiting - Anesthesia Clinical Trials

Preoxygenation Using High Flow Oxygen : Efficacy and Tolerance in Healthy Volunteers

PreOx-OHD
Start date: January 2, 2018
Phase: N/A
Study type: Interventional

High flow nasal cannula oxygen has been proposed to perform preoxygenation in patients with acute respiratory failure requiring orotracheal intubation in intensive care units. However, its use for preoxygenation before the induction of general anaesthesia in operating room has never been evaluated in term of end tidal oxygen fraction which is the gold standard measurement during preoxygenation before general anaesthesia. The goal of the present study is to measure end tidal oxygen after 3 min of preoxygenation using the recommended method (spontaneous breathing of 100% inhaled oxygen through a face mask) and using high flow nasal canula oxygen, in healthy volunteers.

NCT ID: NCT03142295 Recruiting - Safety Issues Clinical Trials

Controlled Human Urine Transfusion for UTI

SHUTUP
Start date: June 24, 2017
Phase: N/A
Study type: Interventional

The primary objective of this pilot study is to investigate the safety and tolerability of controlled human urine transfusion in female patients with recurrent UTI's. Seconday and exploratory objectives are to evaluate the diversity of the urine microbiome after urine transfusion, to assess the longevity of changes in the urine microbiome in patients after urine transfusion over a period of 6 months and to assess the frequency of UTI's after the transfusion.

NCT ID: NCT03120273 Recruiting - Safety Issues Clinical Trials

A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults(Part 2)

Start date: May 5, 2017
Phase: Phase 1
Study type: Interventional

This is a single center, open-label, multiple-dose phase 1 clinical trial. This study will determine the pharmacokinetics (PK), pharmacodynamics (PD), safety and side-effect profile of an investigational dexlansoprazole injection after multiple intravenous administration in healthy Chinese adults.

NCT ID: NCT03105713 Recruiting - Surgery Clinical Trials

Development and Implementation of Patient Safety Checklists Before, During and After In-hospital Surgery

PASC
Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Building on the Norwegian Patient Safety Program's target areas, the Patients' Surgical Checklist (PASC) will empower surgical patients to become more involved in their own safety and contribute to preventive safety measures. A safety checklist for patients to use has been developed and validated for use in surgical patients. In a Stepped Wedge Cluster RCT effects of patients using their own checklists to avoid preventable patient harm are examined. The project will re-use existing health and personal data collected from patient records and patient reported data as outcome measures. A consortium of all relevant stakeholders and users participate: two hospitals with seven surgical clusters, patient representatives, representatives of general practitioners, and interdisciplinary in-hospital professionals. The important project partners are information and communications technology companies (Helse-Vest IKT and CheckWare service delivery), general practitioners, and national and international research partners leading in the field of patient safety, implementation science and health economics.